Management of chronic obstructive pulmonary disease in the elderly

Aging Clinical and Experimental Research

Volumn 16, Issue 1, 2004, Pages 13-21

  Antonelli Incalzi, Raffaele ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Clinical presentation; COPD; Elderly; Misdiagnosis; Multidimensional assessment

Indexed keywords

AMINOPHYLLINE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIURETIC AGENT; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; LONG ACTING DRUG; LOOP DIURETIC AGENT; MUCOLYTIC AGENT; OXAZEPAM; OXYGEN; SEDATIVE AGENT; SHORT ACTING DRUG; STEROID; THEOPHYLLINE;

AGE; AGED; AGITATION; ANOREXIA; ARTIFICIAL VENTILATION; CATARACT; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COPING BEHAVIOR; CORTICOSTEROID INDUCED OSTEOPOROSIS; DEPRESSION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFICACY; DRUG METABOLISM; DYSPNEA; ECHOGRAPHY; FREQUENCY ANALYSIS; GASTROINTESTINAL HEMORRHAGE; GERIATRIC CARE; GLAUCOMA; GLUCOSE INTOLERANCE; HEALTH PROGRAM; HEALTH STATUS; HEART ARRHYTHMIA; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HUMAN; INDEPENDENCE; INSOMNIA; LIFE EXPECTANCY; LUNG EMBOLISM; LUNG FUNCTION TEST; MUSCLE ATROPHY; OCCUPATIONAL THERAPY; OSTEOPOROSIS; OXYGEN THERAPY; PATIENT MONITORING; PROGNOSIS; RESPIRATION DEPRESSION; RESPIRATORY FAILURE; REVIEW; SLEEP DISORDER; SMOKING CESSATION; THROMBOSIS;

EID: 1942438931     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03324526     Document Type: Review

References (71)

1. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-504.
2. Waterer GW, Wan JY, Kritchevsky S, Wunderink RG, et al, for the Health ABC Study. Airflow limitation is underrecognized in well-functioning older people. J Am Geriatr Soc 2001; 49: 1032-8.
3. Bach PB, Brown C, Gelfand SE, et al. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 2001; 134: 600-20.
4. Pelletier-Fleury N, Laone JL, Fleury B, et al. The cost of treating COPD patients with long-term oxygen therapy in a French population. Chest 1996; 110: 411-6.
5. Antonelli Incalzi R, Imperiale C, Bellia V, et al. Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J 2003; 22: 444-9.
6. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. Am J Respir Crit Care 2000; 161: 381-90.
7. Bellia V, Battaglia S, Catalano F, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics. The SaRA Study. Chest 2003; 123: 1066-72.
8. Antonelli Incalzi R, Bellia V, Catalano F, et al. Evaluation of health outcomes in elderly patients with asthma and COPD using disease-specific and generic instruments. The Salute Respiratoria nell'Anziano (Sa.R.A.) Study. Chest 2001; 120: 734-42.
9. Bellia V, Pistelli R, Catalano F, et al. The SA.R.A Study group. Quality control of spirometry in the elderly: the Sa.R.A. Study. Am J Respir Crit Care Med 2000; 161: 1094-100.
10. Curtis R, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease. Am J Respir Crit Care 1997; 156: 1032-9.
11. Antonelli Incalzi R, Fuso L, De Rosa M, et al. Comorbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794-800.
12. Antonelli Incalzi R, Fuso L, De Rosa M, et al. Electrocardiographic signs of chronic cor pulmonare: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation 1999; 99: 1600-5.
13. National Institute of Health. Global Initiative for Chronic Obstructive Lung Disease. Publication no. 2701, April 2001.
14. Antonelli Incalzi R, Bellia V. II trattamento della BPCO in età geriatrica. In Giuntini C, Fabbri L, Grassi V, Eds. I quaderni della BPCO. Torino: Editrice UTET, vol. 5, 2002: 79-86.
15. Zuwallack RL, Mahler DA, Reilly D, et al. Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest 2001; 119: 1661-70.
16. Snider GL. Theophylline in the ambulatory treatment of chronic obstructive lung disease: resolving a controversy. Cleve Clin J Med 1993; 60: 197-201.
17. Goldstein MF, Fallon JJ, Harning R. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 1999; 116: 1733-49.
18. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115-9.
19. Roomi J, Johnson MM, Waters K, et al. Respiratory rehabilitation, exercise capacity and quality of life in chronic airways disease in old age. Age Ageing 1996; 25: 12-6.
20. Rybarczyk B, Gallagher-Thompson D, Rodman J, et al. Applying cognitive-behavioural psychotherapy to the chronically ill elderly: treatment issues and case illustration. Int Psychogeriatr 1992; 4: 127-40.
21. Petty TL, Weinman GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. JAMA 1997; 277: 246-53.
22. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130: 397-403.
23. Cegla JH. Mucolytics - are they useful in chronic mucus hypersecretion? Prophylaxis treatment of airway mucus in COPD. Eur Respir Rev 1992; 2: 289-91.
24. Antonelli Incalzi R, Maini CL, Fuso L, Giordano A, Carbonin PU, Galli G. Effects of aging on mucociliary clearance. Comp Gerontol 1989 (Suppl. A+B); 3: 65-8.
25. Tarpy SP, Celli BR. Long-term oxygen therapy. N Engl J Med 1995; 333: 710-4.
26. Donado JR, Hill NS. Outpatient management. Respir Care Clin North Am 1998; 4: 391-423.
27. Peterson DD, Pack AI, Silage DA, et al. Effects of aging on ventilatory and occlusive pressure responses to hypoxia and hypercapnia. Am Rev Respir Dis 1981; 124: 387-91.
28. Brown LK. Sleep-related disorders and chronic obstructive pulmonary disease. Respir Clin North Am 1998; 4: 493-512.
29. Antonelli Incalzi R, Marra C, Salvigni BL, et al. Does cognitive dysfunction conform to a distinctive pattern in obstructive sleep apnea syndrome? J Sleep Res 2004 (in press).
30. Antonelli Incalzi R, Gemma A, Marra C, Muzzolon R, Capparella O, Carbonin PU. Chronic obstructive pulmonary disease: an original model of cognitive decline. Am Rev Respir Dis 1993; 148: 418-20.
31. Russo-Magno P, O'Brien A, Panciera T, et al. Compliance with CPAP therapy in older men with obstructive sleep apnea. J Am Geriatr Soc 2001; 49: 1205-11.
32. Wong CA, Walsh LJ, Smith CJ, et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000; 355: 1399-403.
33. Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000; 109: 207-12.
34. Antonelli Incalzi R, Caradonna P, Ranieri P, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 2000; 94: 1079-84.
35. Antonelli Incalzi R, Gemma A, Marra C, et al. Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest 1997; 112: 1506-13.
36. Hesselink AE, Penninx BW, Wijnhoven HA, et al. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scand J Prim Health Care 2001; 19: 255-60.
37. Pistelli R, Antonelli Incalzi R, Maini CL, et al. The use of digitalis in patients with chronic respiratory failure. Eur J Respir Dis 1986; 69 (Suppl 146): 549-56.
38. Antonelli Incalzi R, Fuso L, Serra M, et al. Exacerbated chronic obstructive pulmonary disease: a frequently unrecognized condition. J Intern Med 2002; 252: 48-55.
39. Antonelli Incalzi R, Pedone C, Onder G, et al. Predicting length of stay of older patients with exacerbated chronic obstructive pulmonary disease. Aging Clin Exp Res 2001; 13: 49-57.
40. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003; 38: 848-53.
41. Smoller JW, Pollack MH, Otto MW, et al. Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med 1996; 154: 6-17.
42. Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? Circulation 2003; 107: 1514-9.
43. Thurneer R, Muntwyler J, Stammberger U, et al. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest 1997; 112: 122-8.
44. Lindholt JS, Heickendorff L, Antonsen S, et al. Natural history of abdominal aortic aneurysm with and without coexisting chronic obstructive pulmonary disease. J Vasc Urg 1998; 28: 226-33.
45. Russo A, De Luca M, Vigna C, et al. Central pulmonary artery lesions in chronic obstructive pulmonary disease: a transesophageal echocardiography study. Circulation 1999; 100: 1808-15.
46. Schonofer B, Kohler D. Relevance of deep vein thrombosis of the leg in patients with acute exacerbated COPD. Pneumologie 1999; 53: 10-4.
47. Alessandri C, Basili S, Violi F, et al. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Thromb Haemost 1994; 72: 343-6.
48. Simonds AK. Long-term ventilation in obstructive ventilatory disorders. Respir Care Clin North Am 2002; 8: 533-44.
49. Porta R, Appendini L, Vitacca M, et al. Mask proportional assist vs pressure support ventilation in patients in clinically stable condition with chronic ventilatory failure. Chest 2002; 122: 479-88.
50. Schols AMWJ, Soeters PB, Dingemans AMC, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-6.
51. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1414-8.
52. Schols AMWJ, Wouters EFM. Nutrition and metabolic therapy. In Ambrosino N, Donner CF, Rampolla C, Eds. Topics in pulmonary rehabilitation. Pavia: PI-ME Press, 1999: 321-30.
53. Pauwells RA, Buist S, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive disease. Am J Respir Crit Care Med 2001; 163: 1256-76.
54. Fuso L, Antonelli Incalzi R, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995; 98: 272-7.
55. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbations of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996; 154: 950-67.
56. Afessa B. Morales IJ, Scanlon PD, Peters SG. Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure. Crit Care Med 2002; 30: 1610-5.
57. Bellia V, Catalano F, Scichilone N, et al. Sleep disorders in the elderly with and without chronic airflow obstruction: the SaRA study. Sleep 2003; 26: 318-23.
58. Antonelli Incalzi R, Pedone C, Pahor M, et al. Reasons prompting digitalis therapy in the acute care hospital. J Gerontol 2001; 56: M361-5.
59. Saint S, Bent S, Vittinghoff E, et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA 1995; 273: 957-60.
60. Monso E, Garcia-Aymerich J, Soler N, et al. Bacterial infection in exacerbated COPD with changes in sputum characteristics. Epidemiol Infect 2003; 131: 799-804.
61. Murphy TF, Sethi S. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patients. Drugs Aging 2002; 19: 761-5.
62. Blasi F, Damato S, Cosentini R, et al. Chlamydia pneumoniae and chronic bronchitis association with severity and bacterial clearance following treatment. Thorax 2002; 57: 672-6.
63. Fegiz G. Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo. Lung 1991; 169: 69-76.
64. Wollmer P, Ursing K, Midgren B, et al. Inefficiency of chest percussion in the physical therapy of chronic bronchitis. Eur J Respir Dis 1985; 66: 233-9.
65. Alikhan R, Cohen AT, Combe S, et al. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 2003; 14: 341-6.
66. Peter JV, Moran JL, Phillips-Hughes J, et al. Noninvasive ventilation in acute respiratory failure - a meta-analysis update. Crit Care Med 2002; 30: 355-62.
67. Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000; 355: 1931-5.
68. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001; 119: 1691-5.
69. Yohannes AM, Roomi J, Connolly MJ. Elderly people at home disabled by chronic obstructive pulmonary disease. Age Ageing 1998; 27: 523-5.
70. Antonelli Incalzi R, Bellia V, Maggi S, et al. Reversible bronchial obstruction and disease-related health status in COPD. Qual Life Res 2002; 11: 517-25.
71. Antonelli Incalzi R, Pistelli R, Imperiale C, et al. Effects of chronic airway disease on health status of geriatric patients. Aging Clin Exp Res 2004; 16: 26-33.